Cancer101’s Prescription to Learn Platform™ is designed to help navigate patients and caregivers through the information overload they are often confronted with throughout the cancer journey.
LUNGevity Foundation proposed to initiate, design, and execute a study of the benefit and risk assessment that patients undergo when deciding upon the care and/or treatment they wish to receive following a lung cancer diagnosis.
Pancreatic Cancer Action Network’s Know Your Tumor initiative is designed to increase the number of pancreatic cancer patients participating in clinical trials by empowering them with information that assists with treatment decisions.
Click here to read the announcement in the Celgene Newsroom.
Stay tuned for details on the 2015 Innovation Impact Award Program
Awards Program for US residents only